Borno, Hala T <br/><br/>
Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer.  [electronic resource] 

 -  Cancer  02 2019 
 - 453-462 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.31826  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Androgen Antagonists--therapeutic use<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>California--epidemiology<br/>Ethnicity--statistics & numerical data<br/>Hispanic or Latino--statistics & numerical data<br/>Humans<br/>Insurance Coverage--statistics & numerical data<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Orchiectomy--statistics & numerical data<br/>Practice Patterns, Physicians'--statistics & numerical data<br/>Prostatic Neoplasms--drug therapy<br/>Quality of Life<br/>Registries<br/>Socioeconomic Factors<br/>White People--statistics & numerical data